Paper Review Records
All Paper Review Records
17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
136
days
Cytoplasmic CD109 as an Adjunctive Immunohistochemical Marker for High-Grade Differentiated Thyroid Carcinoma Arising from Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
Authors
Tomoko Cohen; Keiji Suzuki; Katsuya Matsuda; Hirokazu Kurohama; Yuki Matsuoka; Kasumi Kawamura; Mayu Ueda; Adiya Kerimbayeva; Ichiro Horie; Shinya Satoh; Hisakazu Shindo; Hiroyuki Yamashita; Masahiro NakashimaShow moreShow less
Affiliations
1. Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; 2. Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; 3. Department of Molecular Oncology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan; 4. Thyroid Cancer Collaborative Research Center, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan; 5. Yamashita Thyroid Hospital, Fukuoka, JapanShow moreShow less
37
days
Validation of the International Medullary Thyroid Carcinoma Grading System in a Multicenter Cohort: Digital Image Analysis-Based Evaluation of Ki-67 Cutoffs and Assessment Methods
Authors
Milim Kim; Su-Jin Shin; Ji-Young Park; Chan Kwon Jung; Jang-Hee Kim; Soo Jin Jung; Jae Kyung Won; Hyeongchan Shin; Jin-Man Kim; Hee Jung Kwon; Jee Yeon Kim; Yeseul Kim; Ju Yeon Pyo; In Ho Choi; Lucia Kim; Hee Young Na; So Yeon ParkShow moreShow less
Affiliations
1. Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 2. Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Department of Pathology, Kyungpook National University Medical Center, Daegu, Republic of Korea; 4. Department of Hospital Pathology, Seoul St. Mary’s Hospital, Seoul, Republic of Korea; 5. Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea; 6. Department of Pathology, Inje University Busan Paik Hospital, Busan, Republic of Korea; 7. Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea; 8. Department of Pathology, Keimyung University Dongsan Hospital, Daegu, Republic of Korea; 9. Department of Pathology, Chungnam National University Hospital, Daejeon, Republic of Korea; 10. Department of Pathology, Gonyang University Medical Center, Daejeon, Republic of Korea; 11. Department of Pathology, Yeungnam University College of Medicine, Daegu, Republic of Korea; 12. Department of Pathology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea; 13. Department of Pathology, Korea University Anam Hospital, Seoul, Republic of Korea; 14. Department of Pathology, Catholic Kwandong University International St. Mary’s Hospital, Incheon, Republic of Korea; 15. Department of Pathology, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea; 16. Department of Pathology, Inha University Hospital, Incheon, Republic of Korea; 17. Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of KoreaShow moreShow less
146
days
IGF2BP3 -Overexpressing Follicular Cell-derived Thyroid Tumors Consist of Low-risk Follicular Patterned Tumors with Frequent HBME-1 Negativity and Distinct Cytomorphologic Features
Authors
André Lametti; Diana Bell; Simion I. Chiosea; Elena Morariu; Kelly McCoy; Linwah Yip; Yuri E. Nikiforov; Raja R. SeethalaShow moreShow less
Affiliations
1. Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA; 2. Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA; 3. Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, USAShow moreShow less
72
days
Multicentre Clinical Validation of the THYT1 Test for Predicting Distant Metastases in Papillary Thyroid Carcinoma
Authors
Benedetta Donati; Federica Torricelli; Cristian Ascione; Moira Ragazzi; Dario De Biase; Thais Maloberti; Andrea Repaci; Luca Di Tommaso; Andrea Lania; Mauro Papotti; Francesco Cabutti; Giovanni Tallini; Davide Giordano; Andrea Frasoldati; Davide Nicoli; Alessia Ciarrocchi; Simonetta PianaShow moreShow less
Affiliations
1. Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 2. Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 3. Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; 4. Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Department of Pharmacy and Biotechnology (FaBit), University of Bologna, Bologna, Italy; 6. Division of Endocrinology and Diabetes, Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 7. Pathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan,, Italy; 8. Department of Biomedical Sciences, Humanitas University, Milan, Italy; 9. Endocrinology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy; 10. Department of Oncology, University of Torino, Turin, Italy; 11. Pathology Unit, Azienda Sanitaria Locale Asti, Asti, Italy; 12. Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; 13. Otolaryngology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 14. Endocrinology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 15. Laboratory of Molecular Pathology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, ItalyShow moreShow less
106
days
Distinct Molecular Pathways Driving Thymic and Pulmonary Neuroendocrine Neoplasms: Organ of Origin Defines Molecular Identity and Yields CD44 as a Marker of Pulmonary Neuroendocrine Tumors
Authors
Hanibal Bohnenberger; Stefan Küffer; Arber Qoku; Julius Bodemeyer; Nelia Nause; Björn Häupl; Kirsten Reuter-Jessen; Tessa Rosenthal; Linja Feldmann; Katharina Ofner; Daniela Frances; Celia Vogel; Christof Lenz; Moritz Jesinghaus; Omar Elakad; Denise Müller; Alexander Otto König; Tobias R. Overbeck; Alexander von Hammerstein-Equord; Marc Hinterthaner; Stefan Welter; Henning Urlaub; Florian Buettner; Thomas Oellerich; Alexander Marx; Philipp StröbelShow moreShow less
Affiliations
1. Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany; 2. Goethe University Frankfurt, Frankfurt am Main, Germany; 3. Institute of Informatics, Goethe University Frankfurt, Frankfurt am Main, Germany; 4. Discovery Life Sciences Biomarker Services GmbH DE, Kassel, Germany; 5. Comprehensive Cancer Center Göttingen (G-CCC), University Medical Center Göttingen, Göttingen, Germany; 6. Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany; 7. Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; 8. Institute of Pathology, Philipps-Universität Marburg, Marburg, Germany; 9. Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center, Göttingen, Germany; 10. Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany; 11. Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, Göttingen, Germany; 12. Department of Thoracic Surgery, Lungenklinik Hemer, Hemer, Germany; 13. Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany; 14. Department of Medicine, Goethe University, Frankfurt, GermanyShow moreShow less
82
days
Comprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations
Authors
Alessandro Vanoli; Erica Travaglino; Frediano Inzani; Tommaso Orione; Federica Grillo; Paola Parente; Paola Spaggiari; Silvia Uccella; Alessandro Zerbi; Anna Caterina Milanetto; Mauro Lecca; Andrea Peri; Antonio Di Sabatino; Marco Paulli; Stefano La Rosa; Matteo Fassan; Edoardo ErrichielloShow moreShow less
Affiliations
1. Department of Molecular Medicine, Unit of Anatomic Pathology, University of Pavia, Pavia, Italy; 2. Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3. Department of Surgical and Integrated Diagnostic Sciences, University of Genova, Genoa, Italy; 4. Anatomic Pathology Unit, AOM IRCCS Ospedale Policlinico San Martino, Genoa, Italy; 5. Pathology Unit, Azienda Ospedaliero-Universitaria Policlinico Riuniti Foggia, Foggia, Italy; 6. Pathology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy; 7. Department of Biomedical Sciences, Humanitas University, Milan, Italy; 8. Pancreatic Surgery Unit, IRCCS Humanitas Research Hospital, Milan, Italy; 9. UniCamillus International Medical University in Rome, Rome, Italy; 10. Pancreatic and Digestive Endocrine Surgery, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; 11. Department of Molecular Medicine, Unit of Medical Genetics, University of Pavia, Pavia, Italy; 12. Department of Surgery, University of Pavia, Pavia, Italy; 13. Surgery 2 Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 14. Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; 15. Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy; 16. Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy; 17. Hereditary Cancer Research Center, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy; 18. Unit of Pathology, ASST Dei Sette Laghi, Varese, Italy; 19. Veneto Institute of Oncology (IOV-IRCCS), Padua, Italy; 20. Department of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Padua, Italy; 21. Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, ItalyShow moreShow less
FAQ
How long does ENDOCRINE PATHOLOGY take to review a manuscript?
As of 2026-11-18, CrushSCI has 17 complete review records for ENDOCRINE PATHOLOGY. The fastest paper went from submission to acceptance in 22 days (Comprehensive Genomic Analysis in Hereditary Adrenal and Extra-Adrenal Paragangliomas, received 2026-07-21, accepted 2026-08-12); the slowest took 204 days. The average is 111.3 days and the median is 119 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
